SP Elixir (OPC) Private Limited

Erlotero (Erlotinib) 150 mg tablets are a medication used to treat certain types of cancer, particularly non-small cell lung cancer (NSCLC) and pancreatic cancer. Erlotinib is an epidermal growth factor receptor (EGFR) inhibitor, meaning it targets and blocks the EGFR protein, which is involved in the growth and spread of cancer cells.

How It Works:

Erlotinib works by inhibiting the EGFR, which is a protein found on the surface of many cells, including cancer cells. EGFR plays a role in cell growth and division. When EGFR is overactive, it can lead to uncontrolled cancer cell growth. By blocking EGFR, Erlotinib can help slow down or stop the growth of cancer cells.

Erlotero (Erlotinib) 150 mg tablets are a targeted therapy used primarily for the treatment of non-small cell lung cancer (NSCLC) and pancreatic cancer. Erlotinib is a tyrosine kinase inhibitor (TKI) that specifically targets the epidermal growth factor receptor (EGFR), which plays a key role in the growth and spread of cancer cells. By inhibiting EGFR, Erlotinib helps to slow down or stop the growth of cancer cells.